Загрузка...
Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy
Regulatory T cells (Tregs) represent a major obstacle of cancer immunotherapy. We reviewed here our discovery that Class I histone deacetylase (HDAC) inhibition can functionally target Tregs and help break the immune tolerance. We also discuss the effects of different classes of HDAC inhibitors on T...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3489755/ https://ncbi.nlm.nih.gov/pubmed/23162767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20306 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|